ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

West Coast Symposium Reports Research Progress On Bone Cancer

November 1, 1974

House Reprogramming Of NCI Funds Analyzed; Community Programs Would Be Hurt

July 13, 1979

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006

CMS Develops New Math of Medicare: Reimbursement Money for Outcomes Data.

February 4, 2005

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

March 30, 2012

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001